Loading…

Retrospective and prospective assessment of butorphanol, azaperone and medetomidine (BAM™) for immobilisation of feral horses (Equus ferus caballus)

Background Butorphanol–azaperone–medetomidine (BAM™) has not been evaluated in horses. Objectives The objective of this study was to evaluate BAM™ for chemical restraint of feral horses. Study design Retrospective and prospective descriptive studies. Methods Data were collected retrospectively from...

Full description

Saved in:
Bibliographic Details
Published in:Equine veterinary journal 2022-05, Vol.54 (3), p.549-555
Main Authors: Balko, Julie A., Fogle, Callie, Stuska, Susan J., Fogle, Jonathan E., Posner, Lysa P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23
cites cdi_FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23
container_end_page 555
container_issue 3
container_start_page 549
container_title Equine veterinary journal
container_volume 54
creator Balko, Julie A.
Fogle, Callie
Stuska, Susan J.
Fogle, Jonathan E.
Posner, Lysa P.
description Background Butorphanol–azaperone–medetomidine (BAM™) has not been evaluated in horses. Objectives The objective of this study was to evaluate BAM™ for chemical restraint of feral horses. Study design Retrospective and prospective descriptive studies. Methods Data were collected retrospectively from medical records of 28 feral horses immobilised with BAM™ over a 6‐year period. Prospectively, 0.0125 mL/kg bwt of BAM™ (butorphanol 27.3 mg/mL, azaperone 9.1 mg/mL and medetomidine 10.9 mg/mL) intramuscularly (im) was administered to eight stallions via dart, and once recumbent, 1.0 mg/kg bwt ketamine was given intravenously (iv). Induction and recovery time and quality via a standardised rubric (1 = very poor; 5 = excellent) and visual analogue scale (VAS), need for additional darts, weight tape measurement and serial physiological parameters were recorded. Serial arterial blood gas analysis was performed during recumbency. Following castration, horses were given 0.1 mg/kg bwt atipamezole (25% iv and 75% im) and allowed to recover unaided. Results Retrospectively, 28 horses were successfully immobilised with BAM™ without a major complication. Prospectively, eight horses were given a median (range) actual BAMTM dose of 0.0143 (0.0127‐0.0510) mL/kg bwt. Three of eight horses needed 1, 2 or 5 additional darts. Median (range) time to recumbency was 11 (2‐44) minutes. Median (range) induction (n = 4) and recovery (n = 6) scores via rubric and VAS were 5 (4‐5) and 5 (5‐5) and 92 (86‐93) and 98 (92‐99) cm, respectively. Four of seven horses were hypoxaemic at ≥1 time point with otherwise acceptable physiological parameters. Following atipamezole, median (range) time to sternal recumbency and standing was 12 (2‐18) and 17 (11‐52) minutes, respectively (n = 6). Main limitations The sample size was small. Data could not be collected before darting or after recovery. Some data were missing from retrospective analysis. Conclusions Intramuscular BAM™ with iv ketamine provided chemical restraint suitable for field castration of feral horses with no mortality. Hypoxaemia occurred in the majority of horses.
doi_str_mv 10.1111/evj.13490
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2543443270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2648904760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23</originalsourceid><addsrcrecordid>eNp1kc9O3DAQxq2KqizQQ18AWeKyKzXgf8nGR0ALtKKqhNpeLScZC6-cONgJCM59hj4Aj8aT1EtoVSHVB9sz_vkbez6EPlBySNM4gtv1IeVCkjdoxohgGeek2EKztM0zWgixjXZiXBPCORPsHdrmgopcUj5Dv65gCD72UA_2FrDuGtz_G8cIMbbQDdgbXI2DD_217rz7iPWD7iH4brrUQgODb21jU2J-cvzl6efjAhsfsG1bX1lnox6s7zYyBoJ2-NqHpI3nq5txjJtcmmtdaefGuNhDb412Ed6_rLvo-9nq2-lFdvn1_NPp8WVW85yTrKBNzpYEhAFNackL4FAzKUHUtZG5Zro0Mp01JTdGCsYbXcjS5EsjK2YqxnfRfNJNn74ZIQ6qtbEG53QHfoyK5YILwVONhB68Qtd-DF16nWKFKCURy2JDLSaqTl2MAYzqg211uFeUqI1ZKpmlns1K7P6L4lil_v0l_7iTgKMJuLMO7v-vpFY_Pk-SvwEffqGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2648904760</pqid></control><display><type>article</type><title>Retrospective and prospective assessment of butorphanol, azaperone and medetomidine (BAM™) for immobilisation of feral horses (Equus ferus caballus)</title><source>Wiley</source><creator>Balko, Julie A. ; Fogle, Callie ; Stuska, Susan J. ; Fogle, Jonathan E. ; Posner, Lysa P.</creator><creatorcontrib>Balko, Julie A. ; Fogle, Callie ; Stuska, Susan J. ; Fogle, Jonathan E. ; Posner, Lysa P.</creatorcontrib><description>Background Butorphanol–azaperone–medetomidine (BAM™) has not been evaluated in horses. Objectives The objective of this study was to evaluate BAM™ for chemical restraint of feral horses. Study design Retrospective and prospective descriptive studies. Methods Data were collected retrospectively from medical records of 28 feral horses immobilised with BAM™ over a 6‐year period. Prospectively, 0.0125 mL/kg bwt of BAM™ (butorphanol 27.3 mg/mL, azaperone 9.1 mg/mL and medetomidine 10.9 mg/mL) intramuscularly (im) was administered to eight stallions via dart, and once recumbent, 1.0 mg/kg bwt ketamine was given intravenously (iv). Induction and recovery time and quality via a standardised rubric (1 = very poor; 5 = excellent) and visual analogue scale (VAS), need for additional darts, weight tape measurement and serial physiological parameters were recorded. Serial arterial blood gas analysis was performed during recumbency. Following castration, horses were given 0.1 mg/kg bwt atipamezole (25% iv and 75% im) and allowed to recover unaided. Results Retrospectively, 28 horses were successfully immobilised with BAM™ without a major complication. Prospectively, eight horses were given a median (range) actual BAMTM dose of 0.0143 (0.0127‐0.0510) mL/kg bwt. Three of eight horses needed 1, 2 or 5 additional darts. Median (range) time to recumbency was 11 (2‐44) minutes. Median (range) induction (n = 4) and recovery (n = 6) scores via rubric and VAS were 5 (4‐5) and 5 (5‐5) and 92 (86‐93) and 98 (92‐99) cm, respectively. Four of seven horses were hypoxaemic at ≥1 time point with otherwise acceptable physiological parameters. Following atipamezole, median (range) time to sternal recumbency and standing was 12 (2‐18) and 17 (11‐52) minutes, respectively (n = 6). Main limitations The sample size was small. Data could not be collected before darting or after recovery. Some data were missing from retrospective analysis. Conclusions Intramuscular BAM™ with iv ketamine provided chemical restraint suitable for field castration of feral horses with no mortality. Hypoxaemia occurred in the majority of horses.</description><identifier>ISSN: 0425-1644</identifier><identifier>EISSN: 2042-3306</identifier><identifier>DOI: 10.1111/evj.13490</identifier><identifier>PMID: 34145913</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; azaperone ; Azaperone - pharmacology ; BAM ; Blood gas analysis ; butorphanol ; Butorphanol - pharmacology ; castration ; horse ; Horses ; Hypnotics and Sedatives - pharmacology ; immobilisation ; Immobilization - veterinary ; Ketamine ; Male ; medetomidine ; Medetomidine - pharmacology ; Physiology ; Prospective Studies ; Retrospective Studies</subject><ispartof>Equine veterinary journal, 2022-05, Vol.54 (3), p.549-555</ispartof><rights>2021 EVJ Ltd</rights><rights>2021 EVJ Ltd.</rights><rights>Copyright © 2022 EVJ Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23</citedby><cites>FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23</cites><orcidid>0000-0003-3667-0623</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34145913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balko, Julie A.</creatorcontrib><creatorcontrib>Fogle, Callie</creatorcontrib><creatorcontrib>Stuska, Susan J.</creatorcontrib><creatorcontrib>Fogle, Jonathan E.</creatorcontrib><creatorcontrib>Posner, Lysa P.</creatorcontrib><title>Retrospective and prospective assessment of butorphanol, azaperone and medetomidine (BAM™) for immobilisation of feral horses (Equus ferus caballus)</title><title>Equine veterinary journal</title><addtitle>Equine Vet J</addtitle><description>Background Butorphanol–azaperone–medetomidine (BAM™) has not been evaluated in horses. Objectives The objective of this study was to evaluate BAM™ for chemical restraint of feral horses. Study design Retrospective and prospective descriptive studies. Methods Data were collected retrospectively from medical records of 28 feral horses immobilised with BAM™ over a 6‐year period. Prospectively, 0.0125 mL/kg bwt of BAM™ (butorphanol 27.3 mg/mL, azaperone 9.1 mg/mL and medetomidine 10.9 mg/mL) intramuscularly (im) was administered to eight stallions via dart, and once recumbent, 1.0 mg/kg bwt ketamine was given intravenously (iv). Induction and recovery time and quality via a standardised rubric (1 = very poor; 5 = excellent) and visual analogue scale (VAS), need for additional darts, weight tape measurement and serial physiological parameters were recorded. Serial arterial blood gas analysis was performed during recumbency. Following castration, horses were given 0.1 mg/kg bwt atipamezole (25% iv and 75% im) and allowed to recover unaided. Results Retrospectively, 28 horses were successfully immobilised with BAM™ without a major complication. Prospectively, eight horses were given a median (range) actual BAMTM dose of 0.0143 (0.0127‐0.0510) mL/kg bwt. Three of eight horses needed 1, 2 or 5 additional darts. Median (range) time to recumbency was 11 (2‐44) minutes. Median (range) induction (n = 4) and recovery (n = 6) scores via rubric and VAS were 5 (4‐5) and 5 (5‐5) and 92 (86‐93) and 98 (92‐99) cm, respectively. Four of seven horses were hypoxaemic at ≥1 time point with otherwise acceptable physiological parameters. Following atipamezole, median (range) time to sternal recumbency and standing was 12 (2‐18) and 17 (11‐52) minutes, respectively (n = 6). Main limitations The sample size was small. Data could not be collected before darting or after recovery. Some data were missing from retrospective analysis. Conclusions Intramuscular BAM™ with iv ketamine provided chemical restraint suitable for field castration of feral horses with no mortality. Hypoxaemia occurred in the majority of horses.</description><subject>Animals</subject><subject>azaperone</subject><subject>Azaperone - pharmacology</subject><subject>BAM</subject><subject>Blood gas analysis</subject><subject>butorphanol</subject><subject>Butorphanol - pharmacology</subject><subject>castration</subject><subject>horse</subject><subject>Horses</subject><subject>Hypnotics and Sedatives - pharmacology</subject><subject>immobilisation</subject><subject>Immobilization - veterinary</subject><subject>Ketamine</subject><subject>Male</subject><subject>medetomidine</subject><subject>Medetomidine - pharmacology</subject><subject>Physiology</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><issn>0425-1644</issn><issn>2042-3306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kc9O3DAQxq2KqizQQ18AWeKyKzXgf8nGR0ALtKKqhNpeLScZC6-cONgJCM59hj4Aj8aT1EtoVSHVB9sz_vkbez6EPlBySNM4gtv1IeVCkjdoxohgGeek2EKztM0zWgixjXZiXBPCORPsHdrmgopcUj5Dv65gCD72UA_2FrDuGtz_G8cIMbbQDdgbXI2DD_217rz7iPWD7iH4brrUQgODb21jU2J-cvzl6efjAhsfsG1bX1lnox6s7zYyBoJ2-NqHpI3nq5txjJtcmmtdaefGuNhDb412Ed6_rLvo-9nq2-lFdvn1_NPp8WVW85yTrKBNzpYEhAFNackL4FAzKUHUtZG5Zro0Mp01JTdGCsYbXcjS5EsjK2YqxnfRfNJNn74ZIQ6qtbEG53QHfoyK5YILwVONhB68Qtd-DF16nWKFKCURy2JDLSaqTl2MAYzqg211uFeUqI1ZKpmlns1K7P6L4lil_v0l_7iTgKMJuLMO7v-vpFY_Pk-SvwEffqGQ</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Balko, Julie A.</creator><creator>Fogle, Callie</creator><creator>Stuska, Susan J.</creator><creator>Fogle, Jonathan E.</creator><creator>Posner, Lysa P.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3667-0623</orcidid></search><sort><creationdate>202205</creationdate><title>Retrospective and prospective assessment of butorphanol, azaperone and medetomidine (BAM™) for immobilisation of feral horses (Equus ferus caballus)</title><author>Balko, Julie A. ; Fogle, Callie ; Stuska, Susan J. ; Fogle, Jonathan E. ; Posner, Lysa P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>azaperone</topic><topic>Azaperone - pharmacology</topic><topic>BAM</topic><topic>Blood gas analysis</topic><topic>butorphanol</topic><topic>Butorphanol - pharmacology</topic><topic>castration</topic><topic>horse</topic><topic>Horses</topic><topic>Hypnotics and Sedatives - pharmacology</topic><topic>immobilisation</topic><topic>Immobilization - veterinary</topic><topic>Ketamine</topic><topic>Male</topic><topic>medetomidine</topic><topic>Medetomidine - pharmacology</topic><topic>Physiology</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balko, Julie A.</creatorcontrib><creatorcontrib>Fogle, Callie</creatorcontrib><creatorcontrib>Stuska, Susan J.</creatorcontrib><creatorcontrib>Fogle, Jonathan E.</creatorcontrib><creatorcontrib>Posner, Lysa P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Equine veterinary journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balko, Julie A.</au><au>Fogle, Callie</au><au>Stuska, Susan J.</au><au>Fogle, Jonathan E.</au><au>Posner, Lysa P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retrospective and prospective assessment of butorphanol, azaperone and medetomidine (BAM™) for immobilisation of feral horses (Equus ferus caballus)</atitle><jtitle>Equine veterinary journal</jtitle><addtitle>Equine Vet J</addtitle><date>2022-05</date><risdate>2022</risdate><volume>54</volume><issue>3</issue><spage>549</spage><epage>555</epage><pages>549-555</pages><issn>0425-1644</issn><eissn>2042-3306</eissn><abstract>Background Butorphanol–azaperone–medetomidine (BAM™) has not been evaluated in horses. Objectives The objective of this study was to evaluate BAM™ for chemical restraint of feral horses. Study design Retrospective and prospective descriptive studies. Methods Data were collected retrospectively from medical records of 28 feral horses immobilised with BAM™ over a 6‐year period. Prospectively, 0.0125 mL/kg bwt of BAM™ (butorphanol 27.3 mg/mL, azaperone 9.1 mg/mL and medetomidine 10.9 mg/mL) intramuscularly (im) was administered to eight stallions via dart, and once recumbent, 1.0 mg/kg bwt ketamine was given intravenously (iv). Induction and recovery time and quality via a standardised rubric (1 = very poor; 5 = excellent) and visual analogue scale (VAS), need for additional darts, weight tape measurement and serial physiological parameters were recorded. Serial arterial blood gas analysis was performed during recumbency. Following castration, horses were given 0.1 mg/kg bwt atipamezole (25% iv and 75% im) and allowed to recover unaided. Results Retrospectively, 28 horses were successfully immobilised with BAM™ without a major complication. Prospectively, eight horses were given a median (range) actual BAMTM dose of 0.0143 (0.0127‐0.0510) mL/kg bwt. Three of eight horses needed 1, 2 or 5 additional darts. Median (range) time to recumbency was 11 (2‐44) minutes. Median (range) induction (n = 4) and recovery (n = 6) scores via rubric and VAS were 5 (4‐5) and 5 (5‐5) and 92 (86‐93) and 98 (92‐99) cm, respectively. Four of seven horses were hypoxaemic at ≥1 time point with otherwise acceptable physiological parameters. Following atipamezole, median (range) time to sternal recumbency and standing was 12 (2‐18) and 17 (11‐52) minutes, respectively (n = 6). Main limitations The sample size was small. Data could not be collected before darting or after recovery. Some data were missing from retrospective analysis. Conclusions Intramuscular BAM™ with iv ketamine provided chemical restraint suitable for field castration of feral horses with no mortality. Hypoxaemia occurred in the majority of horses.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34145913</pmid><doi>10.1111/evj.13490</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3667-0623</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0425-1644
ispartof Equine veterinary journal, 2022-05, Vol.54 (3), p.549-555
issn 0425-1644
2042-3306
language eng
recordid cdi_proquest_miscellaneous_2543443270
source Wiley
subjects Animals
azaperone
Azaperone - pharmacology
BAM
Blood gas analysis
butorphanol
Butorphanol - pharmacology
castration
horse
Horses
Hypnotics and Sedatives - pharmacology
immobilisation
Immobilization - veterinary
Ketamine
Male
medetomidine
Medetomidine - pharmacology
Physiology
Prospective Studies
Retrospective Studies
title Retrospective and prospective assessment of butorphanol, azaperone and medetomidine (BAM™) for immobilisation of feral horses (Equus ferus caballus)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A21%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retrospective%20and%20prospective%20assessment%20of%20butorphanol,%20azaperone%20and%20medetomidine%20(BAM%E2%84%A2)%20for%20immobilisation%20of%20feral%20horses%20(Equus%20ferus%20caballus)&rft.jtitle=Equine%20veterinary%20journal&rft.au=Balko,%20Julie%20A.&rft.date=2022-05&rft.volume=54&rft.issue=3&rft.spage=549&rft.epage=555&rft.pages=549-555&rft.issn=0425-1644&rft.eissn=2042-3306&rft_id=info:doi/10.1111/evj.13490&rft_dat=%3Cproquest_cross%3E2648904760%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-61d5270e4fea11836e3ec299e4ccf95a2a8f9fead83ff9423da698f57f9b2fb23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2648904760&rft_id=info:pmid/34145913&rfr_iscdi=true